跳转至内容
Merck
所有图片(1)

主要文件

查看所有文档

C-008

Supelco

可卡因标准液 溶液

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C17H21NO4
CAS号:
50-36-2
分子量:
303.35
MDL號碼:
MFCD00056906
分類程式碼代碼:
41116107
PubChem物質ID:
329774761
NACRES:
NA.24

等級

certified reference material

品質等級

300

形狀

liquid

特點

SNAP-N-SPIKE®, SNAP-N-SHOOT®

包裝

ampule of 1 mL

製造商／商標名

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IB (Portugal)

濃度

1.0 mg/mL in acetonitrile

技術

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

應用

forensics and toxicology

形式

single component solution

儲存溫度

−20°C

SMILES 字串

COC(=O)[C@H]1[C@H](C[C@@H]2CC[C@H]1N2C)OC(=O)c3ccccc3

InChI

1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1

InChI 密鑰

ZPUCINDJVBIVPJ-LJISPDSOSA-N

一般說明

经认证的加标溶液®适用于法医分析、尿液药物测试或临床毒理学的LC/MS或GC/MS试验应用。可卡因是从古柯植物的叶子中提取的莨菪烷类生物碱和非法药物。这种流行的消遣性药物是中枢神经系统的强大兴奋剂，具有食欲抑制剂和局部麻醉特性。

應用


  • 科研用高纯度盐酸可卡因：研究人员开发了一种使用磁性纳米颗粒对尸检血样中的可卡因及其代谢物进行法医检测的创新分析方法，该研究强调了其在复杂生物基质中检测和定量测定可卡因的准确性（de Souza Schwarz et al., 2024）。


法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相關產品

产品编号
说明
价格

B-004

苯甲酰芽子碱标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

B-001

苯甲酰芽子碱-d3 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-034

Anhydroecgonine methyl ester solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

B-007

苯甲酰芽子碱标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

B-008

苯甲酰芽子碱-d3 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

B-013

苯甲酰牙子碱-D8 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

B-014

苯甲酰牙子碱-D8 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-004

可卡因-D3 溶液, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

C-009

Cocaethylene-D3 solution, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

C-010

可卡乙碱 溶液, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

C-014

可卡因-D3 溶液, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

C-024

Cocaethylene-D8 solution, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

C-088

Cocaine Multi-component Mixture solution, 250 μg/mL each component in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

M-025

Methamphetamine/Cocaine/Heroin solution, 250 μg/mL each component in acetonitrile, ampule of 1.0 mL, certified reference material, Cerilliant®

E-001

芽子碱甲酯标准液 溶液, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

E-002

Ecgonine methyl ester-D3 solution, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

E-004

芽子碱盐酸盐标准液 盐酸盐 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

H-017

m-Hydroxybenzoylecgonine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

L-025

(−)-Levamisole hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-003

去甲可卡因 盐酸盐 溶液, 1.0 mg/mL in acetonitrile (as free base), ampule of 1 mL, certified reference material, Cerilliant®

N-034

Norcocaine-d3 hydrochloride, 100 μg/mL in acetonitrile (as free base), ampule of 1 mL, certified reference material, Cerilliant®

H-135

对羟基可卡因 盐酸盐 溶液, 1 mg/mL in acetonitrile (as free base), certified reference material, ampule of 1 mL, Cerilliant®

象形圖

FlameExclamation mark
GHS02,GHS07

訊號詞

Danger

危險分類

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2

儲存類別代碼

3 - Flammable liquids

水污染物質分類（WGK）

WGK 2

閃點（°F）

35.6 °F - closed cup

閃點（°C）

2 °C - closed cup

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Carlos Manuel Lima Reis da Silva et al.
Journal of psychoactive drugs, 45(2), 195-198 (2013-08-03)
The topic of ophthalmic use of cocaine in clinical practice has a long history; nevertheless, the possible influence and pathways of action of inhaled cocaine in the human eye remain unknown. This study evaluates the effect of snorted cocaine in
Coca science seeks an answer in kilos.
Antonio Regalado
Science (New York, N.Y.), 341(6145), 453-453 (2013-08-03)
Watchareewan Thongsaard et al.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 96 Suppl 1, S85-S89 (2013-06-04)
Thunbergia laurifolia Linn. (TL) is a herbal medicine used as an antidote for several poisonous agents in Thai traditional medicine. TL were reported not only to significantly increase potassium-stimulated dopamine release from rat striatal slices but also potentiated the effect
Thomas C Jhou et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 33(17), 7501-7512 (2013-04-26)
Many strong rewards, including abused drugs, also produce aversive effects that are poorly understood. For example, cocaine can produce aversive conditioning after its rewarding effects have dissipated, consistent with opponent process theory, but the neural mechanisms involved are not well
Xiaoqing Cai et al.
Journal of medicinal chemistry, 56(9), 3701-3709 (2013-05-01)
Presently, there are no FDA-approved medications to treat cocaine addiction. Active vaccination has emerged as one approach to intervene through the rapid sequestering of the circulating drug, thus terminating both psychoactive effects and drug toxicity. Herein, we report our efforts
查看所有相关文献

商品

Benefits of Ascentis Express Phenyl-Hexyl over Biphenyl for the Separation of Pain Management Opiates

Although both biphenyl and phenyl-hexyl phases can resolve these compounds, the former exhibits excellent peak shape and substantially less silanol-derived ion exchange activity.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门